476 related articles for article (PubMed ID: 7594922)
1. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
2. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Norman G; Joseph G; Richard J
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
[TBL] [Abstract][Full Text] [Related]
3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
4. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
[TBL] [Abstract][Full Text] [Related]
5. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
[TBL] [Abstract][Full Text] [Related]
6. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
8. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
[TBL] [Abstract][Full Text] [Related]
9. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
Gelber RH; Balagon VF; Cellona RV
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
[TBL] [Abstract][Full Text] [Related]
10. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
12. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
13. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
14. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
[TBL] [Abstract][Full Text] [Related]
15. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
[TBL] [Abstract][Full Text] [Related]
16. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
17. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
18. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
19. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
